Rights and permissions
About this article
Cite this article
The antiglaucoma drug latanoprost has gained approval in the European Union. Inpharma Wkly. 1093, 22 (1997). https://doi.org/10.1007/BF03315227
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03315227